Core Service

What does MediRama do?

We are Clinical Development & Commercialization Expert Group
We provide a one-stop, consolidated clinical development & commercialization service (ABCD Platform)

Clinical/Regulatory Consulting

Clinical Strategy
: Indication prioritization, non-clinical gap analysis, accelerated approval planning, TPP, 1a/1b synopsis, protocol development
Regulatory Strategy & Engagement
- FDA: ODD, FTD, BTD
- MFDS: ODD
- Regulatory Engagement: FDA/MFDS Pre-IND/IND & Type B, C, D meetings
- IND/NDA Support: Approval-driven regulatory strategy, gap analysis, CMC/non-clinical/clinical evaluation
Advisory Committee

CRO & Trial Management

CRO Services
: IND, startup, monitoring, PV, data management/statistics,
medical writing and logistics
Trial Excellence
: Sponsor-side study team, site/investigator selection & management, regulatory interaction, CRO oversight, medical monitoring, DSUR/IB update, IDMC/DSMB operation
Patient & Risk Management
: Investigator meetings, recruitment strategy, risk assessment & mitigation,
response-type analysis for protocol refinement
Quality Control
My MD & My PM

Commercial Consulting

Corporate Portfolio & Business Strategy
Licensing Deals for Pipeline Products
- Business development consulting (BD strategy, partnering, valuation,
negotiation, counteract and term sheet)
Business Strategy for Local Market
- Market access, launch, distribution, promotion, PR, alliance, etc.

Clinical & Regulatory Consulting

From clinical development stage, MediRama can help you with

  • Comprehensive clinical development strategy: Identifying unmet needs, selecting clinical indications
  • Clinical trial operation/management: Selecting and overseeing clinical vendors and investigators, communication with regulatory authorities
Partnership
What Biotech and Pharmaceutical companies do well

Drug candidate development up to the preclinical stage

  • Platform development

  • Target identification

  • Lead optimization

  • Preclinical studies

  • CMC (Chemistry, Manufacturing, and Controls)

What MediRama does well

Clinical Development for New Drug

  • Development of a regulatory strategy roadmap specialized in clinical medicine

  • Competent MDs and PMs

  • Clinical development operation based on medical and clinical development knowledge

  • Individual clinical trial operation

    : Conducting clinical trials in compliance with regulatory agency/IRB regulations

Success in Clinical Development

Drug Approval (NDA/BLA)

CRO & Trial Management

MediRama’s CRO Model  “Client = MediRama”

Commercial Consulting

MediRama: Clinical Experts for Commercial Success

  • MediRama is a team of clinical development experts specializing in strategic trials and regulatory pathways to accelerate drug approval and commercialization.
    We help maximizing the asset value and driving successful business growth for drug developers.
Concerns
  • R&D

    Is your R&D/portfolio strategy aligned with your company's vision and business strategy?

  • Licensing

    Can this actively developed asset be successfully out-licensed?

  • Business

    Finding partners for global markets—but what’s the strategy for domestic business?

How MediRama Assists

Corporate Portfolio Strategy Consulting

  • Strategic Portfolio Assessment & Planning through

  • Current portfolio composition and future therapeutic focus

  • Commercial capabilities and differentiation from competitors

  • Alignment of development/acquisition pipeline with the existing portfolio

  • Go/No-Go decisions for development and in-licensing projects

Comprehensive Support for Licensing Deals

  • Strategy & Analysis: Business development strategy, market & competitive analysis, valuation

  • Partnering: Screening, shortlist creation, BD deck development

  • Execution: Partnering events, product pitching, negotiations, contract support

Business Strategy for the Domestic Market

  • Market access, launch, distribution & promotion, PR, alliance, etc.